New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
09:06 EDTACADACADIA price target raised to $42 from $28 at Piper Jaffray
Piper Jaffray raised its price target for ACADIA Pharmaceuticals to $42 citing the company's pipeline progress following its Q4 results. The firm keeps an Overweight rating on the stock.
News For ACAD From The Last 14 Days
Check below for free stories on ACAD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ACAD

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use